Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Nasal Glucagon vs Intramuscular Glucagon in Japanese Patients With Diabetes Mellitus
jRCT2080223805Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of glucagon in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM) and hypoglycaemia (2 arms), sponsored by Eli Lilly and Company. Started Feb 2018; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)hypoglycaemia
Beyond the preview
Go deeper on jRCT2080223805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223805.